- Report
- November 2025
- 192 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- November 2025
- 183 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- October 2025
- 184 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- August 2025
- 196 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- August 2025
- 190 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- August 2025
- 192 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- June 2025
- 400 Pages
Global
From €4373EUR$4,949USD£3,853GBP
- Report
- June 2025
- 92 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- July 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
€4286EUR$4,850USD£3,776GBP
- Report
- August 2024
- 150 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP
- Report
- May 2024
- 250 Pages
Global
From €4414EUR$4,995USD£3,889GBP
- Report
- September 2024
- 117 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- August 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,614GBP
€3491EUR$3,950USD£3,075GBP

The Synthetic Biomaterial market is a subset of the larger Biomaterials market, which encompasses materials used in medical and healthcare applications. Synthetic Biomaterials are man-made materials that are designed to interact with biological systems, such as the human body. These materials are used in a variety of medical applications, including implants, prosthetics, and drug delivery systems. Synthetic Biomaterials are designed to be biocompatible, meaning they are non-toxic and do not cause an immune response. They are also designed to be durable and long-lasting, allowing them to be used in a variety of medical applications.
Some companies in the Synthetic Biomaterial market include Corbion, PolyOne Corporation, Evonik Industries, Solvay, and BASF. Show Less Read more